Csenge Advisory Group’s Clorox CLX Stock Holding History

Csenge Advisory Group’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,862	Closed	-$333K	–	631
2021 Q4	$333K	Buy	1,862 +21	+1%	+$3.5K	0.03%	430
2021 Q3	$303K	Sell	1,841 -21	-1%	-$3.62K	0.03%	466
2021 Q2	$333K	Buy	+1,862	New	+$340K	0.03%	431
2021 Q1	–	Sell	-1,462	Closed	-$295K	–	494
2020 Q4	$295K	Sell	1,462 -37	-2%	-$7.66K	0.04%	329
2020 Q3	$317K	Buy	1,499 +356	+31%	+$79.3K	0.04%	295
2020 Q2	$251K	Buy	+1,143	New	+$228K	0.04%	308
2020 Q1	–	Sell	-1,367	Closed	-$210K	–	301
2019 Q4	$210K	Sell	1,367 -242	-15%	-$36.2K	0.05%	269
2019 Q3	$245K	Buy	+1,609	New	+$254K	0.07%	229
2019 Q2	–	Sell	-2,115	Closed	-$339K	–	196
2019 Q1	$339K	Buy	2,115 +85	+4%	+$13.2K	0.12%	133
2018 Q4	$312K	Buy	2,030 +1,400	+222%	+$218K	0.11%	137
2018 Q3	$100K	Buy	+630	New	+$89.5K	0.04%	234
2017 Q4	–	Sell	-3,978	Closed	-$525K	–	256
2017 Q3	$525K	Buy	+3,978	New	+$535K	0.21%	112

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Csenge Advisory Group's CLX Position: Q1 2022 in Review

Csenge Advisory Group sold out of Clorox (CLX) in Q1 2022, closing a stake of 1,862 shares — an estimated $333K sold.

Csenge Advisory Group first reported a position in CLX in Q3 2017 and held it in 12 quarters. The position peaked at $525K in Q3 2017. 1,093 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

Csenge Advisory Group reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
Csenge Advisory Group sold 1,862 Clorox shares in Q1 2022, an estimated $333K.
Csenge Advisory Group first reported a position in Clorox in Q3 2017 and held it in 12 quarters.
Csenge Advisory Group's Clorox position peaked at $525K in Q3 2017.
1,093 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Csenge Advisory Group's 13F filing for Q1 2022, filed 9 May 2022.